日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer

USP10/GSK3β介导的PTEN抑制导致乳腺癌对PI3K抑制剂产生耐药性

Kumari, Nishi; Wright, Sarah Ce; Witham, Christopher M; Monserrat, Laia; Palafox, Marta; Richard, John Lc; Costa, Carlotta; Elkabets, Moshe; Agostino, Mark; Klemm, Theresa; Eccles, Melissa; Garnham, Alex; Wu, Ting; Nilsson, Jonas A; Walz, Nikita; Venugopal, Veena; Cerra, Anthony; Vasilevski, Natali; Bridgeman, Stephanie; Bassi, Sona; Saei, Azad; Helal, Moutaz; Neundorf, Philipp; Riedel, Angela; Rosenfeldt, Mathias; Gill, Jespal; Pahor, Nikolett; Hartmann, Oliver; Chung, Jacky; Sidhu, Sachdev S; Moderau, Nina; Jha, Sudhakar; Rodon, Jordi; Diefenbacher, Markus E; Komander, David; Serra, Violeta; Eichhorn, Pieter Johan Adam

The mutational landscape of the adult healthy parous and nulliparous human breast

成年健康已生育和未生育人类乳腺的突变情况

Biancastella Cereser, Angela Yiu, Neha Tabassum, Lisa Del Bel Belluz, Sladjana Zagorac, Kenneth Russell Zapanta Ancheta, Rongrong Zhong, Cristian Miere, Alicia Rose Jeffries-Jones, Nina Moderau, Benjamin Werner, Justin Stebbing

In vivo bioassay to test the pathogenicity of missense human AIP variants

体内生物测定法检测错义人类AIP变异体的致病性

Aflorei, Elena Daniela; Klapholz, Benjamin; Chen, Chenghao; Radian, Serban; Dragu, Anca Neluta; Moderau, Nina; Prodromou, Chrisostomos; Ribeiro, Paulo S; Stanewsky, Ralf; Korbonits, Márta

Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?

利用 Caris 分子智能平台对肿瘤进行分子分析能否改善癌症患者的治疗效果?

Carter, Philip; Alifrangis, Costi; Cereser, Biancastella; Chandrasinghe, Pramodh; Belluz, Lisa Del Bel; Herzog, Thomas; Levitan, Joel; Moderau, Nina; Schwartzberg, Lee; Tabassum, Neha; Wen, Jinrui; Krell, Jonathan; Stebbing, Justin

Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans

对晚期乳腺癌肿瘤进行分子谱分析有助于辅助临床治疗方案的制定。

Carter, Philip; Alifrangis, Costi; Cereser, Biancastella; Chandrasinghe, Pramodh; Del Bel Belluz, Lisa; Moderau, Nina; Poyia, Fotini; Schwartzberg, Lee S; Tabassum, Neha; Wen, Jinrui; Krell, Jonathan; Stebbing, Justin

Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments

研究分子谱分析在指导晚期非小细胞肺癌治疗中的益处

Alifrangis, Costi; Carter, Philip; Cereser, Biancastella; Chandrasinghe, Pramodh; Belluz, Lisa Del Bel; Lim, Eric; Moderau, Nina; Poyia, Fotini; Tabassum, Neha; Zhang, Hua; Krell, Jonathan; Stebbing, Justin

Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy

评估肿瘤分子谱以指导晚期女性生殖道恶性肿瘤患者的治疗

Carter, Philip; Alifrangis, Costi; Cereser, Biancastella; Chandrasinghe, Pramodh; Del Bel Belluz, Lisa; Fotopoulou, Christina; Frilling, Andreja; Herzog, Thomas; Moderau, Nina; Tabassum, Neha; Krell, Jonathan; Stebbing, Justin

The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas

肿瘤分子谱分析在预测结直肠腺癌治疗中的益处

Carter, Philip; Alifrangis, Costi; Chandrasinghe, Pramodh; Cereser, Biancastella; Del Bel Belluz, Lisa; Leo, Cosimo Alex; Moderau, Nina; Tabassum, Neha; Warusavitarne, Janindra; Krell, Jonathan; Stebbing, Justin

Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy

更正:评估肿瘤分子谱以指导晚期女性生殖道恶性肿瘤患者的治疗

Carter, Philip; Alifrangis, Costi; Cereser, Biancastella; Chandrasinghe, Pramodh; Del Bel Belluz, Lisa; Fotopoulou, Christina; Frilling, Andreja; Herzog, Thomas; Moderau, Nina; Tabassum, Neha; Krell, Jonathan; Stebbing, Justin

Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?

更正:使用 Caris 分子智能平台对肿瘤进行分子分析能否改善癌症患者的治疗效果?

Carter, Philip; Alifrangis, Costi; Cereser, Biancastella; Chandrasinghe, Pramodh; Del Bel Belluz, Lisa; Herzog, Thomas; Levitan, Joel; Moderau, Nina; Schwartzberg, Lee; Tabassum, Neha; Wen, Jinrui; Krell, Jonathan; Stebbing, Justin